SCHEMBL12403290

SCHEMBL12403290

CCOC(=O)CN(CC(=O)OCC)CC(O)COc1ccc(C(c2ccc(OCC(O)CN(CC(=O)OCC)CC(=O)OCC)cc2)C(c2ccc(OCC(O)CN(CC(=O)OCC)CC(=O)OCC)cc2)c2ccc(OCC(O)CN(CC(=O)OCC)CC(=O)OCC)cc2)cc1

nearest known ligand 0.46

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.46
▸ GAA P10253 2/20 0.46
▸ TSHR P16473 1/20 0.46
▸ KDM4E B2RXH2 1/20 0.46
▸ MAPK1 P28482 1/20 0.46
▸ TDP1 Q9NUW8 1/20 0.46
▸ LMNA P02545 2/20 0.45
▸ ABCB1 P08183 1/20 0.44
▸ POLB P06746 3/20 0.42
▸ MAPT P10636 2/20 0.41
▸ NPSR1 Q6W5P4 2/20 0.41
▸ CYP1A2 P05177 1/20 0.41
▸ CYP2D6 P10635 1/20 0.41
▸ CYP2C9 P11712 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12403157 0.92 ALDH1A1 (0.46) ALDH1A1GAATSHRKDM4EMAPK1
SCHEMBL14373227 0.87 LTA4H (0.50) ALDH1A1GAATSHRKDM4EMAPK1
SCHEMBL12403169 0.79 LTA4H (0.43) ALDH1A1GAATSHRKDM4EMAPK1
SCHEMBL12403447 0.75 ALDH1A1 (0.55) ALDH1A1GAATSHRKDM4EMAPK1
SCHEMBL14409204 0.74 ALDH1A1 (0.58) ALDH1A1GAATSHRKDM4EMAPK1
SCHEMBL12403459 0.73 ALDH1A1 (0.52) ALDH1A1GAATSHRKDM4EMAPK1
SCHEMBL12403297 0.72 MAPK1 (0.52) ALDH1A1GAATSHRKDM4EMAPK1
SCHEMBL7088132 0.72 MAPT (0.58) ALDH1A1TSHRLMNAABCB1POLB
SCHEMBL12881505 0.71 USP2 (0.58) ALDH1A1TSHRKDM4ELMNAPOLB
SCHEMBL13246331 0.70 POLB (0.58) ALDH1A1GAATSHRKDM4EMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7985424-B2 Dendritic polymers with enhanced amplification and interior functionality DENDRITIC NANOTECHNOLOGIES INC. (US) 2011-07-26 — — US disclosed
US-7985424-B2 Dendritic polymers with enhanced amplification and interior functionality DENDRITIC NANOTECHNOLOGIES INC. (US) 2011-07-26 — — US disclosed
US-20070298006-A1 Dendritic Polymers With Enhanced Amplification and Interior Functionality DENDRITIC NANOTECHNOLOGIES, INC. (US) 2007-12-27 — — US disclosed
US-20070298006-A1 Dendritic Polymers With Enhanced Amplification and Interior Functionality DENDRITIC NANOTECHNOLOGIES, INC. (US) 2007-12-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070298006-A1 Dendritic Polymers With Enhanced Amplification and Interior Functionality MYD88, TLR3, TMEM97 ALDH1A1 2720/4885GAA 2744/4885TSHR 3651/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback